Dianthus Therapeutics Inc
NASDAQ:DNTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Variman Global Enterprises Ltd
BSE:540570
|
IN |
|
H
|
HDB Financial Services Ltd
NSE:HDBFS
|
IN |
|
H
|
Hitevision Co Ltd
SZSE:002955
|
CN |
|
J
|
Jiangyin Electrical Alloy Co Ltd
SZSE:300697
|
CN |
|
Justin Allen Holdings Ltd
HKEX:1425
|
CN |
|
Sapphire Foods India Ltd
NSE:SAPPHIRE
|
IN |
|
I
|
Integrated Design & Engineering Holdings Co Ltd
TSE:9161
|
JP |
|
Nitta Gelatin Inc
TSE:4977
|
JP |
During the last 3 months Dianthus Therapeutics Inc insiders have not bought any shares, and sold 10.6m USD worth of shares. The stock price has increased by 100% over this period (open performance analysis).
The last transaction was made on
Apr 9, 2026
by
Savitz Ryan
, who
sold
738.8k USD
worth of 
DNTH shares.
During the last 3 months Dianthus Therapeutics Inc insiders have not bought any shares, and sold 10.6m USD worth of shares. The stock price has increased by 100% over this period (open performance analysis).
The last transaction was made on
Apr 9, 2026
by
Savitz Ryan
, who
sold
738.8k USD
worth of DNTH shares.
Dianthus Therapeutics Inc
Glance View
Dianthus Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Cambridge, Massachusetts and currently employs 67 full-time employees. The company went IPO on 2018-06-21. Dianthus Therapeutics, Inc., formerly Magenta Therapeutics, Inc., is a clinical-stage biotechnology company engaged in designing and delivering monoclonal antibodies. The Company’s lead antibody, DNTH103, is engineered with an extended half-life, improved potency, and high selectivity for only the active C1s complement protein that drives disease pathology, enabling less frequent and more convenient self-administered subcutaneous injections. DNTH103 is an investigational, long-acting monoclonal antibody engineered to potently and selectively inhibit the active form of C1s, a clinically validated target in the classical complement pathway. As the classical pathway plays a significant role in disease pathology across a range of neuromuscular disorders, DNTH103 holds the potential to be a pipeline in a product beginning with generalized Myasthenia Gravis (gMG), Multifocal Motor Neuropathy and Chronic Inflammatory Demyelinating Polyneuropathy.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
